title: The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?
abstract: The proteasome is believed to participate in the generation of a large percentage of peptide ligands for MHC class I molecules. This conclusion is based largely on the activities of peptidyl aldehydes that block proteasome activity. We tested the ability of a panel of proteasome inhibitors to affect the generation of MHC class I binding peptides in mouse L929 cells. Included in the panel are peptidyl aldehydes and a microbial product, lactacystin, that blocks proteasome activity in a distinct and more specific manner. Contrary to expectations, proteasome inhibitors failed to block the generation of a large portion of high affinity peptides as inferred by measuring cell surface expression of newly synthesized MHC class I molecules. These findings were confirmed by examining the effects of the inhibitors on the presentation of individual antigenic determinants from endogenously synthesized or exogenously delivered influenza virus proteins. Presentation of peptides derived from exogenous basic polymerase 1, endogenous basic polymerase 1, and nonstructural-1 proteins was decreased by inhibitors in a manner consistent with proteasomal involvement. Presentation of peptides derived from endogenous nucleoprotein was not significantly affected by the proteasome inhibitors, while presentation of exogenous hemagglutinin and nucleoprotein was enhanced by the proteasome inhibitors. These data are consistent with the involvement of both proteasomes and nonproteasomal cytosolic proteases in the generation of a significant portion of MHC class I binding peptides.
authors.affiliation: Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, NY 10029, USA.
authors.forename: A
authors.initials: A
authors.lastname: Vinitsky
authors.forename: L C
authors.initials: LC
authors.lastname: Antón
authors.forename: H L
authors.initials: HL
authors.lastname: Snyder
authors.forename: M
authors.initials: M
authors.lastname: Orlowski
authors.forename: J R
authors.initials: JR
authors.lastname: Bennink
authors.forename: J W
authors.initials: JW
authors.lastname: Yewdell
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000187:drug effects; D000956:Antigens, Viral / Q000276:immunology; D002460:Cell Line; D003546:Cysteine Endopeptidases / Q000276:immunology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D008024:Ligands; D051379:Mice; D009097:Multienzyme Complexes / Q000276:immunology*; D009975:Orthomyxoviridae / Q000276:immunology; D010455:Peptides / Q000276:immunology*; D046988:Proteasome Endopeptidase Complex; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; D004791:Enzyme Inhibitors; D015395:Histocompatibility Antigens Class I; D008024:Ligands; D009097:Multienzyme Complexes; D010455:Peptides; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex